سعر اديسين 500 مجم فيال للحقن الوريدي 2024

Vancomycin 500 mg powder for IV infusion (Global Pharmaceutical Industries, Egypt).

• Treatment of serious infections caused by susceptible Gram-positive bacteria, including methicillin-resistant staphylococci, when other antibiotics are inappropriate (US IV vancomycin labeling, ingredient/formulation-level).Population: Adults and pediatric (per label)DailyMed (NLM)

• Hypersensitivity to vancomycin.General active-ingredient information · DailyMed (NLM)

• Nephrotoxicity and ototoxicity; infusion-related reactions (red-man syndrome) with rapid infusion; Clostridioides difficile-associated diarrhea; monitor renal function and vancomycin levels as appropriate.General active-ingredient information · DailyMed (NLM)

• Other nephrotoxic / ototoxic agents (e.g., aminoglycosides)MajorAdditive nephrotoxicity and ototoxicity risk.DailyMed (NLM)

• Systemic vancomycin crosses the placenta; use only if clearly needed with monitoring considerations (ingredient-level from US labeling context).General active-ingredient information · DailyMed (NLM)

• Vancomycin: Binds D-Ala-D-Ala termini of peptidoglycan precursors and blocks cell-wall cross-linking.